Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanford-Burnham Hopes $275 Million Gift Will Translate To Returns

Executive Summary

As NIH funding becomes increasingly scarce, the La Jolla, Calif., research institute will use an anonymously donated gift to emphasize translational projects and take internal risk. Will it deliver returns that sustain the organization?

You may also be interested in...



CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics

Non-profit hospital spins out its first start-up, which will house one program to address a heritable form of blindness, another to treat hemophilia B.

Roche Taps Scientific Heavyweight John Reed To Head Early Pharma R&D

Roche has enlisted John Reed - head of the La Jolla-based Sanford-Burnham Medical Research Institute - to lead the Swiss group’s non-Genentech pharmaceutical R&D efforts.

Craig Venter Wants To Extend Your Life (And Own Your Data)

The onetime Celera CEO says his new attempt to centralize biological information into a massive database could lead to breakthroughs that extend the human life span. Behind that bold goal is a more mundane data-licensing strategy that, although not splashy, could still improve medicine.

Topics

Related Companies

Related Deals

Latest News
See All
UsernamePublicRestriction

Register

PS055958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel